In this issue:
Icotrokinra for moderate-to-severe psoriasis
Mediterranean diet for psoriasis
Psoriasis and risk of cancer
GLP1 receptor agonists and reduced mortality, cardiovascular and psychiatric risks in psoriasis
Real-world treatment patterns in patients with GPP in the US
Safety and efficacy of envudeucitinib in moderate-to-severe plaque psoriasis
Efficacy and safety of cannabidiol oil in psoriasis
New-onset psoriasis following
COVID-19 infection or vaccination
Roflumilast 0.3% cream for nail psoriasis
Effectiveness and drug persistence of methotrexate, cyclosporine, and acitretin for psoriasis
Please login below to download this issue (PDF)